These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25984871)

  • 1. ACP Journal Club. Review: Perioperative β-blockade reduces nonfatal MI but increases mortality in noncardiac surgery.
    Brown DL
    Ann Intern Med; 2015 May; 162(10):JC10. PubMed ID: 25984871
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
    Wijeysundera DN; Duncan D; Nkonde-Price C; Virani SS; Washam JB; Fleischmann KE; Fleisher LA
    J Am Coll Cardiol; 2014 Dec; 64(22):2406-25. PubMed ID: 25091545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hazards of perioperative β-blockers are likely to be dose related.
    Dimmitt SB; Stampfer HG; Warren JB; Paech MJ
    Br J Anaesth; 2015 Dec; 115(6):944. PubMed ID: 26582863
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC.
    Anderson JL; Antman EM; Harold JG; Jessup M; O'Gara PT; Pinto FJ; Vardas PE; Zamorano JL
    J Am Coll Cardiol; 2014 Dec; 64(22):2371-2. PubMed ID: 25091542
    [No Abstract]   [Full Text] [Related]  

  • 5. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
    Fleisher LA; Fleischmann KE; Auerbach AD; Barnason SA; Beckman JA; Bozkurt B; Davila-Roman VG; Gerhard-Herman MD; Holly TA; Kane GC; Marine JE; Nelson MT; Spencer CC; Thompson A; Ting HH; Uretsky BF; Wijeysundera DN; ;
    J Am Coll Cardiol; 2014 Dec; 64(22):e77-137. PubMed ID: 25091544
    [No Abstract]   [Full Text] [Related]  

  • 6. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Wijeysundera DN; Duncan D; Nkonde-Price C; Virani SS; Washam JB; Fleischmann KE; Fleisher LA;
    Circulation; 2014 Dec; 130(24):2246-64. PubMed ID: 25085964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Jacobs AK; Anderson JL; Halperin JL
    J Am Coll Cardiol; 2014 Sep; 64(13):1373-84. PubMed ID: 25103073
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
    Jacobs AK; Anderson JL; Halperin JL; ; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Fleisher LA; Gidding S; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Wijeysundera DN
    Circulation; 2014 Sep; 130(14):1208-17. PubMed ID: 25092464
    [No Abstract]   [Full Text] [Related]  

  • 9. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.
    Fleisher LA; Beckman JA; Brown KA; Calkins H; Chaikof E; Fleischmann KE; Freeman WK; Froehlich JB; Kasper EK; Kersten JR; Riegel B; Robb JF; Smith SC; Jacobs AK; Adams CD; Anderson JL; Antman EM; Faxon DP; Fuster V; Halperin JL; Hiratzka LF; Hunt SA; Lytle BW; Nishimura R; Page RL; Riegel B; ; ; ; ; ; ;
    Circulation; 2006 Jun; 113(22):2662-74. PubMed ID: 16754815
    [No Abstract]   [Full Text] [Related]  

  • 10. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS;
    Circulation; 2015 Dec; 132(22):e267-72. PubMed ID: 26527714
    [No Abstract]   [Full Text] [Related]  

  • 11. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JA; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL;
    Circulation; 2015 Dec; 132(22):e281-91. PubMed ID: 26621645
    [No Abstract]   [Full Text] [Related]  

  • 12. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].
    Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; Ellenbogen KA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hayes DL; Page RL; Stevenson LW; Sweeney MO; ; ;
    Circulation; 2012 Oct; 126(14):1784-800. PubMed ID: 22965336
    [No Abstract]   [Full Text] [Related]  

  • 13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE;
    Circulation; 2015 Dec; 132(22):e292-7. PubMed ID: 26621646
    [No Abstract]   [Full Text] [Related]  

  • 14. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH;
    Circulation; 2015 Dec; 132(22):e262-6. PubMed ID: 26621643
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Guyton RA; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK
    Circulation; 2013 Apr; 127(13):1425-43. PubMed ID: 23457117
    [No Abstract]   [Full Text] [Related]  

  • 16. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
    ; ; ; ; Wann LS; Curtis AB; Ellenbogen KA; Estes NA; Ezekowitz MD; Jackman WM; January CT; Lowe JE; Page RL; Slotwiner DJ; Stevenson WG; Tracy CM; Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey J; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann LS
    Circulation; 2013 May; 127(18):1916-26. PubMed ID: 23545139
    [No Abstract]   [Full Text] [Related]  

  • 18. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH;
    Circulation; 2015 Dec; 132(22):e343-5. PubMed ID: 26527715
    [No Abstract]   [Full Text] [Related]  

  • 19. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB;
    Circulation; 2015 Dec; 132(22):e298-302. PubMed ID: 26621647
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ;
    Circulation; 2015 Dec; 132(22):e310-4. PubMed ID: 26621649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.